Related by context. Frequent words. (Click for all words.) 61 cell lymphoma PTCL 55 follicular non 54 Metastatic 54 IMC A# 53 xenograft models 53 cell lymphomas 53 Chronic Lymphocytic Leukemia 53 relapsed refractory 52 cutaneous T cell 52 metastatic renal cell carcinoma 52 axitinib 52 allogeneic stem cell 52 Acute Myeloid Leukemia AML 51 chronic lymphocytic leukemia CLL 51 poorer prognosis 51 castration resistant prostate cancer 51 TELCYTA 51 SPIRIT III 50 cell malignancies 50 B CLL 50 myeloid 50 lymphomas 50 refractory multiple myeloma 50 decitabine 50 GVAX immunotherapy 49 unresectable 49 Bortezomib 49 aHUS 49 DLBCL 49 peripheral blood mononuclear 49 temsirolimus 49 phase 2a 49 events AEs 49 IMGN# 49 neoplastic 49 IIa clinical trial 49 glioblastoma multiforme GBM 48 Phase 2a clinical 48 dasatinib 48 relapsed multiple myeloma 48 lupus nephritis 48 ASA# 48 Carcinoma 48 refractory peripheral T 48 neoadjuvant chemotherapy 48 soft tissue sarcomas 48 hematological malignancies 48 randomized Phase III 48 EGFR inhibitors 48 Relapsed 48 BAY #-# 48 ocrelizumab 48 CD# + [002] 47 azacitidine 47 Phase 2b trial 47 non squamous 47 acute myeloid leukemia AML 47 Trastuzumab 47 acute myelogenous leukemia AML 47 PXD# 47 distant metastases 47 Treanda 47 recurrent ovarian cancer 47 GvHD 47 nilotinib 47 bone metastasis 47 neoplasm 47 squamous 47 HGS ETR1 47 hematologic 47 subgroup analyzes 47 Genasense 47 cell lymphoma 47 Acute Myeloid Leukemia 47 clofarabine 47 prognostic factors 47 Vectibix 47 hematologic cancers 47 neoadjuvant 47 TORISEL 47 lymphoid 47 BCX# 47 Phase 1b clinical 47 TREANDA 47 adenocarcinomas 47 febrile neutropenia 47 hematological cancers 47 Phase 2b clinical 47 hormone refractory prostate cancer 46 EGFR targeting 46 medullary thyroid cancer 46 GRN#L 46 AP# [003] 46 vinorelbine 46 VIDAZA 46 phase IIa 46 eculizumab 46 fibrotic 46 Voir IRIN droits d' 46 Phase 2a trial 46 EpCAM